Viewing Study NCT00240305


Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2025-12-26 @ 2:02 AM
Study NCT ID: NCT00240305
Status: COMPLETED
Last Update Posted: 2009-03-16
First Post: 2005-10-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module